Why the study?
Does a modified method for measuring total creatine phosphokinase release accurately estimate myocardial infarct size in patients with acute myocardial infarction?
Does a modified method for measuring total creatine phosphokinase release accurately estimate myocardial infarct size in patients with acute myocardial infarction?
A modified method for measuring total creatine phosphokinase release correlates well with clinical indices of myocardial damage, providing a useful tool for estimating infarct size.
No takes yet. Share an insight, caveat, or question.
May support infarct size estimation in AMI; extends prior enzyme methods but leaves open prospective validation before clinical use.
Norris et al. (1975) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: